Robertv Baumgartner News Today

New Mexico Educational Retirement Board trimmed its stake in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 4.2% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,300 shares of the biotechnology company’s stock after selling 100 shares during the period. New Mexico Educational Retirement Board’s holdings […]

Bio-Techne (NASDAQ:TECH – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Friday, Zacks.com reports. The firm currently has a $408.00 price target on the biotechnology company’s stock. Zacks Investment Research‘s price objective would indicate a potential upside of 14.79% from […]

Shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) have been assigned an average recommendation of “Buy” from the eight ratings firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have assigned a buy recommendation to the company. […]

Bio-Techne (NASDAQ:TECH – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It […]

Several analysts have recently updated their ratings and price targets for Bio-Techne (NASDAQ: TECH): 5/12/2022 – Bio-Techne was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $394.00 price target on the stock. According to Zacks, “Bio-Techne Corporation is a global life sciences company. It […]